Literature DB >> 16037973

Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome.

Christoph Schmidauer1, Martin Sojer, Klaus Seppi, Heike Stockner, Birgit Högl, Birgit Biedermann, Elisabeth Brandauer, Cecilia M Peralta, Gregor K Wenning, Werner Poewe.   

Abstract

In patients with Parkinson's disease, hyperechogenicity of the substantia nigra using transcranial ultrasound has been related to increased tissue concentrations of iron. Recently, deficient iron transport mechanisms in substantia nigra neurons have been described in postmortem tissue of patients with restless legs syndrome (RLS). This study was performed to study substantia nigra echogenicity in RLS patients compared with normal control subjects and Parkinson's disease patients. RLS patients had significantly reduced midbrain areas of hyperechogenicity compared with control subjects, and even more markedly reduced hyperechogenicity compared with Parkinson's disease patients. These findings lend further support to nigral iron deficiency as a pathogenetic factor in RLS.

Entities:  

Mesh:

Year:  2005        PMID: 16037973     DOI: 10.1002/ana.20572

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  50 in total

Review 1.  Restless legs syndrome: pathophysiology, clinical presentation and management.

Authors:  Claudia Trenkwalder; Walter Paulus
Journal:  Nat Rev Neurol       Date:  2010-06       Impact factor: 42.937

Review 2.  Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.

Authors:  Uwe Walter
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

3.  Restless legs and substantia nigra hypoechogenicity are common features in Friedreich's ataxia.

Authors:  Matthis Synofzik; Jana Godau; Tobias Lindig; Ludger Schöls; Daniela Berg
Journal:  Cerebellum       Date:  2011-03       Impact factor: 3.847

4.  A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome.

Authors:  Christopher J Earley; Alena Horská; Mona A Mohamed; Peter B Barker; John L Beard; Richard P Allen
Journal:  Sleep Med       Date:  2008-02-14       Impact factor: 3.492

5.  Recent advances in the diagnosis, genetics and treatment of restless legs syndrome.

Authors:  Claudia Trenkwalder; Birgit Högl; Juliane Winkelmann
Journal:  J Neurol       Date:  2009-04-27       Impact factor: 4.849

6.  Basal ganglia hyperechogenicity does not distinguish between patients with primary dystonia and healthy individuals.

Authors:  Johann Hagenah; Inke R König; Charlotte Kötter; Günter Seidel; Christine Klein; Norbert Brüggemann
Journal:  J Neurol       Date:  2010-11-02       Impact factor: 4.849

Review 7.  An update on the pathophysiology and genetics of restless legs syndrome.

Authors:  Lynn Marie Trotti; Srinivas Bhadriraju; David B Rye
Journal:  Curr Neurol Neurosci Rep       Date:  2008-07       Impact factor: 5.081

Review 8.  [Iron deficiency, Fatigue and Restless-Legs-Syndrome].

Authors:  Bettina Wurzinger; Peter König
Journal:  Wien Med Wochenschr       Date:  2016-08-30

9.  Iron-deficiency and dopaminergic treatment effects on RLS-Like behaviors of an animal model with the brain iron deficiency pattern of the restless legs syndrome.

Authors:  Richard P Allen; Christopher J Earley; Byron C Jones; Erica L Unger
Journal:  Sleep Med       Date:  2020-02-05       Impact factor: 3.492

10.  Diurnal cycle influences peripheral and brain iron levels in mice.

Authors:  Erica L Unger; Christopher J Earley; John L Beard
Journal:  J Appl Physiol (1985)       Date:  2008-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.